Shared on08 Sep 25Fair value Increased 0.99%
Tenet Healthcare’s consensus price target was revised slightly higher to $199.48, as strong Q2 earnings and positive hospital sector sentiment drove analyst optimism, though some caution remains around 2026 estimates and cost pressures. Analyst Commentary Bullish analysts cite Tenet Healthcare's Q2 results exceeding expectations, leading to multiple price target increases.
Shared on30 Apr 25Fair value Increased 1.52%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Increased 2.82%
AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.
Shared on16 Apr 25Fair value Decreased 0.42%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 1.51%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Decreased 0.36%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Decreased 11%
AnalystConsensusTarget has increased revenue growth from 3.5% to 3.9%, increased profit margin from 5.2% to 5.8% and decreased future PE multiple from 17.3x to 13.9x.